Retrospective analysis of low-dose interleukin-2 therapy on chronic autoimmune thyroid disease with concurrent systemic lupus erythematosus

INTRODUCTION: Low-dose interleukin-2 (IL-2) regulates the homeostasis of CD4(+) T cells by modulating the proportions of effector and regulatory T cells, thus reducing disease activity in patients with systemic lupus erythematosus (SLE). However, to date, no research has been carried out on the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Naidi, Jin, Yuebo, Cheng, Gong, Zhang, Kai, Huang, Bo, Li, Yuhui, He, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392266/
https://www.ncbi.nlm.nih.gov/pubmed/37489616
http://dx.doi.org/10.1080/07853890.2023.2238600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392266/
https://www.ncbi.nlm.nih.gov/pubmed/37489616
http://dx.doi.org/10.1080/07853890.2023.2238600

Ejemplares similares